| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Rosett Max is a Chief Financial Officer at IMNM. Recent filings cover 0 purchases and 4 sales.
Our model assigns Rosett Max a middling insider score of 65/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +38.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | IMNM Immunome, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 60,000 | $18.23 | $1,093,800.00 | -52.6% | +35.9% | - | |
| Apr 2, 2026 | IMNM Immunome, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 65,000 | $21.92 | $1,424,916.08 | -54.6% | -1.6% | - | |
| Sep 19, 2024 | IMNM Immunome Inc. | Chief Financial Officer | Sale+OE | 14,380 | $16.01 | $230,223.80 | -23.2% | -27.3% | -38.6% |